Patent · US Active

Inhibitors of F18+ E coli binding

US8703722B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

UNIVERSITEIT GENT · BE

Inventors

Annelies Coddens · Merelbeke, BE
Eric Cox · Merelbeke, BE
Susann Teneberg · Hagfors, SE

Key dates

Filing date	Sep 30, 2009
Grant date	Apr 22, 2014
Priority date	—
Expiry date	Feb 24, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to blood group A/B/H determinant on Type 1 Core glycosphingolipids chains as recognition point for the FedF protein of F18-fimbriated Enterotoxigenic and verotoxinogenic Escherichia coli and the use of compounds comprising such determinants for the treatment of F18+ E. coli infections in pigs and in screening methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.